The CDPE is leading a rapid assessment of the COVID-19 pandemic’s impact on people who inject drugs in Toronto.

The pilot for Toronto’s Drug Checking Service, which checked and publicly reported on more than 10,000 samples between October 10, 2019, and June 30, 2023, was coordinated by the CDPE. While Toronto’s Drug Checking Service now operates from its own unit within MAP Centre for Urban Health Solutions at St. Michael’s Hospital, a site of Unity Health Toronto, the CDPE continues to work collaboratively with and conduct scientific research on the program.

The CDPE’s smartphone-based portable drug checking device was one of three finalists for Health Canada’s drug checking technology challenge.

The CDPE has conducted an international cross comparison of illegal drug policies to create an online tool – the Drug Policy Metrics Map – to demonstrate the alignment and gaps between the metrics that countries use to assess the success of their drug policy and the actual drug policy-related outcomes they experience.

The CDPE is leading a study to evaluate the impact of integrating supervised injection services within community healthcare agencies in Toronto, Ontario.

The Policy Impact Unit works in partnership with drug policy stakeholders – including people who use drugs, affected communities, civil society, and policymakers – to support the development of evidence- and rights-based drug policies in Canada and around the globe.

PRIMER is a multi-country study on the impact of different interventions in preventing people who use drugs from initiating others into injection drug use.

The CDPE is leading a study to evaluate the impact of safer opioid supply programs in Toronto, Ontario.

The CDPE is synthesizing the evidence on the effectiveness of drug policies and interventions to reduce drug-related harms.

#CannabisClaims is a campaign addressing common misconceptions related to cannabis use and regulation.